SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-24-031076
Filing Date
2024-03-05
Accepted
2024-03-05 16:57:28
Documents
5

Document Format Files

Seq Description Document Type Size
1 425 tm248016d1_425.htm 425 23078
2 GRAPHIC tm248016d1_img001.jpg GRAPHIC 26912
3 GRAPHIC tm248016d1_img002.jpg GRAPHIC 27762
4 GRAPHIC tm248016d1_img003.jpg GRAPHIC 23632
5 GRAPHIC tm248016d1_img004.jpg GRAPHIC 30989
  Complete submission text file 0001104659-24-031076.txt   176152
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filed by) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588
Business Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588 (925) 463-4800
Peak Bio, Inc. (Subject) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39951 | Film No.: 24721842
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)